ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

$24.81
+1.74 (+7.54%)
As of Mar 25, 9:58 PM ET ·
Financial Highlights (FY 2025)
Revenue
878.33M
Net Income
120.27M
Gross Margin
62.0%
Profit Margin
13.7%
Rev Growth
+6.0%
D/E Ratio
0.25
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 62.0%
Operating Margin 19.3% 20.1% 18.6%
Profit Margin 13.7% 18.2% 15.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 878.33M 917.39M 923.52M
Gross Profit 544.48M 568.69M 572.49M
Operating Income 169.52M 184.08M 171.32M
Net Income 120.27M 166.79M 141.53M
Gross Margin 62.0% 62.0% 62.0%
Operating Margin 19.3% 20.1% 18.6%
Profit Margin 13.7% 18.2% 15.3%
Rev Growth +6.0% +16.1% -7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 414.28M 427.86M 516.43M
Total Equity 1.64B 1.41B 1.63B
D/E Ratio 0.25 0.30 0.32
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 272.46M 241.94M 249.41M
Free Cash Flow 126.96M 147.40M 173.90M